v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Millions, $ in Millions
CNY (¥)
shares
USD ($)
shares
Total shareholders' equity
CNY (¥)
Ordinary Shares
CNY (¥)
shares
Additional paid-in capital
CNY (¥)
Treasury shares
CNY (¥)
Subscription receivables
CNY (¥)
Statutory reserves
CNY (¥)
Cumulative translation adjustments
CNY (¥)
Unrealized gains (losses) on interest rate swaps and others
CNY (¥)
Retained earnings
CNY (¥)
Noncontrolling interest
CNY (¥)
Balance at Mar. 31, 2023 ¥ 1,113,063   ¥ 989,657 ¥ 1 ¥ 416,880 ¥ (28,763) ¥ (49) ¥ 12,977 ¥ (10,476) ¥ 59 ¥ 599,028 ¥ 123,406
Balance (in shares) at Mar. 31, 2023 | shares       20,526,017,712                
Increase (Decrease) in Stockholders' Equity                        
Foreign currency translation adjustment, net of tax 13,499   13,005       (3)   13,006 2   494
Share of additional paid-in capital and other comprehensive income of equity method investees 682   682   (298)       981 (1)    
Change in fair value of interest rate swaps under hedge accounting and others (97)   (97)             (97)    
Net income for the year 71,151   80,009               80,009 (8,858)
Acquisition of subsidiaries 98                     98
Deconsolidation of subsidiaries 148   124           124     24
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options 842   842   842              
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options (in shares) | shares       192,305,904                
Repurchase and retirement of ordinary shares 89,076   89,076   29,313 1,079         60,842  
Repurchase and retirement of ordinary shares (in shares) | shares       (1,249,196,660)                
Transactions with noncontrolling interests (6,724)   (1,375)   (1,375)             (5,349)
Amortization of compensation cost 17,393   11,531   11,531             5,862
Declaration of dividends (18,542)   (18,542)               (18,542)  
Appropriation to statutory reserves               1,756     (1,756)  
Others 566   216   (268)   ¥ 52         350
Balance at Mar. 31, 2024 1,101,871   986,544 ¥ 1 397,999 (27,684)   14,733 3,635 (37) 597,897 115,327
Balance (in shares) at Mar. 31, 2024 | shares       19,469,126,956                
Increase (Decrease) in Stockholders' Equity                        
Foreign currency translation adjustment, net of tax (168)   (182)           (183) 1   14
Share of additional paid-in capital and other comprehensive income of equity method investees 186   186   (53)       178 61    
Change in fair value of interest rate swaps under hedge accounting and others 82   82             82    
Net investment hedges (344)   (344)           (344)      
Net income for the year 125,912   130,109               130,109 (4,197)
Acquisition of subsidiaries 587                     587
Deconsolidation of subsidiaries 16,251                     16,251
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options 8   8   8              
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options (in shares) | shares       202,166,984                
Repurchase and retirement of ordinary shares (85,650)   (85,650)   25,020 (8,645)         51,985  
Repurchase and retirement of ordinary shares (in shares) | shares       (1,197,058,232)                
Transactions with noncontrolling interests (24,835)   794   794             (25,629)
Amortization of compensation cost 13,796   10,518   10,518             3,278
Declaration of dividends (29,340)   (29,340)               (29,340)  
Capped call transactions (4,612)   4,612   4,612              
Appropriation to statutory reserves               1,203     (1,203)  
Others (2,849)   (1,745)   (1,745)             (4,594)
Balance at Mar. 31, 2025 ¥ 1,078,393   1,009,858 ¥ 1 381,379 (36,329)   15,936 3,286 107 645,478 68,535
Balance (in shares) at Mar. 31, 2025 | shares 18,474,235,708 18,474,235,708   18,474,235,708                
Increase (Decrease) in Stockholders' Equity                        
Foreign currency translation adjustment, net of tax ¥ (11,737)   (11,387)           (11,397) 10   (350)
Share of additional paid-in capital and other comprehensive income of equity method investees (24)   (24)   295       (774) 455    
Change in fair value of interest rate swaps under hedge accounting and others (238) $ (35) (238)             (238)    
Net investment hedges (4,519)   (4,519)           (4,519)      
Net income for the year 101,177   103,592               103,592 (2,415)
Acquisition of subsidiaries 824                     824
Deconsolidation of subsidiaries 139                     139
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options 1,038   1,038   1,038              
Issuance of shares, including vesting of RSUs and early exercised options and exercise of share options (in shares) | shares       178,872,058                
Repurchase and retirement of ordinary shares 7,535   7,535   1,737 (167)         5,965  
Repurchase and retirement of ordinary shares (in shares) | shares       (72,733,488)                
Transactions with noncontrolling interests (15,795)   (12,884)   (12,884)             (2,911)
Amortization of compensation cost (11,541)   10,213   10,213             1,328
Declaration of dividends (34,031)   (34,031)               (34,031)  
Capped call transactions (1,309)   1,309   1,309              
Appropriation to statutory reserves               692     (692)  
Others (779)   (8,112)   (8,091) (21)           7,333
Balance at Mar. 31, 2026 ¥ 1,118,425 $ 162,138 ¥ 1,060,886 ¥ 1 ¥ 385,086 ¥ (36,141)   ¥ 16,628 ¥ (13,404) ¥ 334 ¥ 708,382 ¥ 57,539
Balance (in shares) at Mar. 31, 2026 | shares 18,580,374,278 18,580,374,278   18,580,374,278